EE358 Efficiency of Third-Generation Antiseizure Medications in Spain for Drug-Resistant Epilepsy: A Cost-per-Number Needed to Treat Analysis
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.604
https://www.valueinhealthjournal.com/article/S1098-3015(22)02808-X/fulltext
Title :
EE358 Efficiency of Third-Generation Antiseizure Medications in Spain for Drug-Resistant Epilepsy: A Cost-per-Number Needed to Treat Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02808-X&doi=10.1016/j.jval.2022.09.604
First page :
Section Title :
Open access? :
No
Section Order :
10139